Children. Teens. Adults. Seniors. Blood cancers strike ruthlessly at any age. And while no two blood cancers are alike – whether leukemia, lymphoma, or myeloma -- treatment responses vary greatly. This human need serves as our inspiration.
Today, Pfizer has seven medicines available globally, across leukemias and lymphomas, and bringing hope relief to thousands of people. Our dedication to creating breakthrough medicines also manifests in our partnerships with the blood cancer community. We develop resources to enhance quality care and provide access to medicine, supporting those with blood cancer throughout their journey.
Pfizer seeks to invest in game-changing science to deliver tomorrow’s breakthroughs for diseases that represent significant areas of need for innovation. Our in-depth understanding of the science behind blood cancers and the leadership we have developed across our existing blood cancer medicines positions us for success as we begin to bring breakthroughs for people with multiple myeloma.
We have a long-standing commitment to blood cancer because we know that when we combine our resilience, scientific expertise, collaborative spirit, passion, and agility we can offer hope for people with these diseases. For the millions living today and diagnosed tomorrow, we will work relentlessly to deliver on our mission: breakthroughs that change patients’ lives.
Pfizer Inc. 235 East 42nd Street NY, NY 10017 (212) 733-2323
If you are a Healthcare Professional or Consumer seeking medical information about our prescription products, please contact Pfizer Medical Information or visit us at Medical Information for Patients | Pfizer Medical Information - US.
|Access Date||Quiz Result||Score||Actions|
Please make sure the password is typed in ALL CAPS and includes the exclamation point. Enter the email address that you used to register for the conference.